There is disclosed a method for treating Equine Metabolic Syndrome (EMS) comprising administering an acetyl cholinesterase inhibitor compound to the suspected EMS horse. The present disclosure further provides a method for treating feline or canine diabetes and feline or canine renal disease comprising administering an acetyl cholinesterase inhibitor compound to the suspected feline or canine.